ACL, states, and other partners strengthen No Wrong Door systems by analyzing data to:
- Identify best practices in program implementation
- Develop resources to assist partners in learning and replicating best practices
- Provide information for governmental agencies, stakeholders, and the public to advocate for support and address sustainability efforts
- Produce reports on No Wrong Door activities for Congress
- Identify needs for targeted technical assistance
Properly collected and analyzed No Wrong Door system data can provide a picture of how community-based organizations succeed and where they need to improve.
Check out the Success Stories for additional insights into No Wrong Door's impact.
In the most recent (2023) LTSS Scorecard Report,No Wrong Door was among the top three indicators to show improvement, and two-thirds of states made progress toward fully functional status with their No Wrong Door systems.
Data Highlights
Data reported by grantees (April 2020-September 2022) representing No Wrong Door partners across all 50 states, D.C., and four U.S. territories (American Samoa, Guam, Northern Mariana Islands, and Puerto Rico) demonstrated the impact of No Wrong Door systems.
No Wrong Door grantees leveraged their existing infrastructure and community partnerships to increase vaccine access for populations of all ages and all disabilities and facilitated more than 66,000 transitions from institutions — such as hospitals and nursing homes — back to the community (typically helping a person return home). Partnerships and outreach campaigns are prominent examples of successful initiatives facilitated by No Wrong Door funding. Strategic partnerships enabled grantees to effectively navigate accessibility issues and other barriers faced when trying to return home. No Wrong Door grantees used their funds to form lasting partnershipswith other community-based organizations (e.g., faith-based, kinship care), healthcare entities, and health departments, as well as expand their reach through cost effective innovative approachesto vaccine access.
